These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1503436)

  • 1. Identification of factors affecting in vivo aminoglycoside activity in an experimental model of gram-negative endocarditis.
    Potel G; Caillon J; Le Gallou F; Bugnon D; Le Conte P; Raza J; Lepage JY; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1992 Apr; 36(4):744-50. PubMed ID: 1503436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
    Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gentamicin-resistant Serratia marcescens endophthalmitis.
    Gammon JA; Schwab I; Joseph P
    Arch Ophthalmol; 1980 Jul; 98(7):1221-3. PubMed ID: 6994702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.
    Dubé L; Caillon J; Jacqueline C; Bugnon D; Potel G; Asseray N
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2545-7. PubMed ID: 22395262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial effectiveness of sisomicin. I: In vitro activity of sisomicin compared with gentamicin, tobramycin, amikacin and kanamycin (author's transl)].
    Schassan HH
    Infection; 1976; 4(2):35-41. PubMed ID: 789246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the bactericidal activity of three aminosides: gentamicin, tobramycin and amikacin].
    Juvin ME; Drugeon HB; Caillon J; Pirault JL
    Pathol Biol (Paris); 1987 May; 35(5):461-5. PubMed ID: 3302848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity.
    Garraffo R; Drugeon HB; Dellamonica P; Bernard E; Lapalus P
    Antimicrob Agents Chemother; 1990 Apr; 34(4):614-21. PubMed ID: 2111658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative evaluation of five aminoglycosides for treatment.
    Rosin H; Naumann P; Reintjens E; Köhler M
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):157-67. PubMed ID: 820656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the susceptibility patterns of gram-negative organisms isolated in cancer centres with aminoglycoside usage.
    Muscato JJ; Wilbur DW; Stout JJ; Fahrlender RA
    J Antimicrob Chemother; 1991 May; 27 Suppl C():1-7. PubMed ID: 1906860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
    Langstaff D; Schueler S; Righter J
    J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model.
    Bugnon D; Potel G; Xiong YQ; Caillon J; Kergueris MF; Le Conte P; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1996 May; 40(5):1164-9. PubMed ID: 8723459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
    Thornsberry C; Barry AL; Jones RN; Baker CN; Badal RE; Packer RR
    Antimicrob Agents Chemother; 1980 Aug; 18(2):338-45. PubMed ID: 7447410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.
    Meyer RD; Lewis RP; Halter J; White M
    Lancet; 1976 Mar; 1(7959):580-3. PubMed ID: 55850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of aminoglycoside usage on susceptibilities.
    Flournoy DJ
    Chemotherapy; 1985; 31(3):178-80. PubMed ID: 3922684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.
    Drasar FA; Farrell W; Maskell J; Williams JD
    Br Med J; 1976 Nov; 2(6047):1284-7. PubMed ID: 1000196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.